Taiho Oncology Patient SupportTM for you and your patients
Taiho Oncology Patient SupportTM for you and your patients
Jump to Billing and Coding
Meeting the access needs of your patients
Taiho Oncology Patient Support offers personalized services to help patients, caregivers, and healthcare professionals access Taiho Oncology products. This includes insurance coverage determination and help with medication affordability. For more information, please visit or refer patients to TaihoPatientSupport.com.
Getting patients access to their medicine is an important step. Taiho Oncology Patient Support strives to make this process as simple as possible.
Financial support
Eligible, commercially insured patients can enroll in the Taiho Oncology Patient Support Co-Pay Program, which may help reduce out-of-pocket expenses to $0* for their treatment with LONSURF. To determine patient eligibility, visit TaihoOncologyCoPay.com or call 1‑844‑TAIHO‑4U (1‑844‑824‑4648).
*Restrictions and eligibility: Offer valid in the US, Puerto Rico, and US territories only. Only valid for patients with private insurance. Offer not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, Tricare, or other federal or state programs (such as medical assistance programs). If the patient is eligible for drug benefits under any such program, this offer is not valid and the patient cannot use this offer. By presenting or accepting this benefit, patient and pharmacist agree not to submit claim for reimbursement under the above programs. Patient further agrees to comply with any and all terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. It is illegal to or offer to sell, purchase, or trade this benefit. Maximum reimbursement limits apply; patient out-of-pocket expense may vary. Taiho Oncology, Inc., reserves the right to rescind, revoke, or amend this offer at any time without notice.
Insurance Coverage Support
- Benefits investigation
- Prior authorization assistance
- Appeals assistance
- Coordination of prescriptions with pharmacies
Patient Affordability Assistance*
- $0 Co-Pay Program enrollment for eligible commercially insured patients
- Patient assistance program designed to provide free medication to eligible patients who are uninsured or underinsured
- Referrals to third-party foundations for co-pay or other assistance based on eligibility and additional criteria
- Referrals to Medicare Part D Low-Income Subsidy (LIS)/Extra Help Program
Personalized Nurse Support†
- One-on-one nurse educational support for patients, available via opt-in
- Nurse support with the LONSURF Patient Treatment Kit. Request a kit:
Online
TaihoPatientSupport.com
By phone
1‑844‑TAIHO‑4U
(1-844-824-4648)
*Visit TaihoPatientSupport.com to see full eligibility criteria.
†If this option is selected on the Patient Enrollment Form, a Nurse Navigator will be assigned to provide telephone support and will address general inquiries about LONSURF, your patient's Oncology medicine treatment.
Enroll in Taiho Oncology Patient Support Services:
By fax
- Download the Enrollment Form, and print it out to complete
- Fax the completed form to 1‑844‑287‑2559
Billing and coding information1
Effective from October 1, 2023, through September 30, 2024, the following ICD-10 diagnosis codes for LONSURF may help your practice with reimbursement. ICD codes continually change, so consult your ICD-10 code book or contact the payer for coding and billing guidance.
Metastatic colorectal cancer | |
| ICD-10-CM | Description |
| C18.0 | Malignant neoplasm of cecum |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C20 | Malignant neoplasm of rectum |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus, and anal canal |
| C78.5 | Secondary malignant neoplasm of large intestine and rectum |
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum |
| D37.4 | Neoplasm of uncertain behavior of colon |
| D37.5 | Neoplasm of uncertain behavior of rectum |
Metastatic gastric cancer | |
| ICD-10-CM | Description |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
This information is not intended as coverage or coding advice and does not guarantee reimbursement. You should verify the appropriate reimbursement information for services or items you provide. Each healthcare professional is responsible for ensuring all coding is accurate and appropriate.